Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Free Cash Flow (2016 - 2025)

Arcadia Biosciences filings provide 12 years of Free Cash Flow readings, the most recent being -$839000.0 for Q4 2025.

  • On a quarterly basis, Free Cash Flow rose 61.55% to -$839000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$4.7 million, a 50.72% increase, with the full-year FY2025 number at -$4.7 million, up 50.72% from a year prior.
  • Free Cash Flow hit -$839000.0 in Q4 2025 for Arcadia Biosciences, down from -$300000.0 in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of -$300000.0 in Q3 2025 to a low of -$8.5 million in Q3 2021.
  • Median Free Cash Flow over the past 5 years was -$3.3 million (2022), compared with a mean of -$3.5 million.
  • Biggest five-year swings in Free Cash Flow: crashed 72.6% in 2023 and later skyrocketed 82.88% in 2025.
  • Arcadia Biosciences' Free Cash Flow stood at -$6.7 million in 2021, then surged by 64.36% to -$2.4 million in 2022, then crashed by 72.6% to -$4.2 million in 2023, then skyrocketed by 47.43% to -$2.2 million in 2024, then soared by 61.55% to -$839000.0 in 2025.
  • The last three reported values for Free Cash Flow were -$839000.0 (Q4 2025), -$300000.0 (Q3 2025), and -$2.0 million (Q2 2025) per Business Quant data.